Login to My NLA Account

News Stories

Jan, 2021

JACKSONVILLE, Fla. – (January 6, 2021) -- The National Lipid Association (NLA) is proud to announce that it has achieved reaccreditation status from Joint Accreditation for Interprofessional Continuing Education for a new six-year term through November 2026. This recent reaccreditation enables the NLA to continue development of medical education for the entire healthcare team and maintain its reputation for delivering the highest quality education to its membership and beyond.

0
No votes yet
Name: NLA News
Dec, 2020

National Lipid Association Announces Late-Breaking Abstract Presentations at NLA 2020 Virtual Scientific Sessions

 
JACKSONVILLE, Fla. – (December 10, 2020) – The National Lipid Association announced today that it will feature three key late breaking scientific abstract presentations at its 2020 Virtual Scientific Sessions starting today. The late-breaker abstracts include:
 

    0
    No votes yet
    Name: NLA News
    Aug, 2020

    Regeneron Pharmaceuticals, Inc. today announced that the New England Journal of Medicine (NEJM) published positive results from the Phase 3 trial of evinacumab in 65 patients with homozygous familial hypercholesterolemia (HoFH).

    0
    No votes yet
    Name: NLA News